Chart calendar Biofrontera AG
Upcoming events on Biofrontera AG
Past events on Biofrontera AG
2024-05-31 03:05 am | Q1 2024 Earnings Release |
2024-05-13 | Reverse Split: 1 of 21; Rights Issue: 1 new share @ 1.1 EUR of 1 existing share |
2024-05-13 | Rights Issue: 1 new share @ 1.1 EUR for 1 existing share |
2024-04-30 04:15 am | Q4 2023 Earnings Release |
2024-04-04 05:00 am | Extraordinary Shareholders Meeting |
2023-08-31 04:00 am | Q2 2023 Earnings Release |
2023-06-20 05:30 am | Annual General Meeting |
2023-05-31 08:00 am | Q1 2023 Earnings Call |
2023-05-31 05:30 am | Q1 2023 Earnings Release |
2023-04-27 05:20 pm | Q4 2022 Earnings Release |
2022-11-22 | Q3 2022 Earnings Release |
2022-10-27 | Rights Issue: 1 new share @ 1 EUR for 8 existing shares |
2022-08-23 05:00 am | Annual General Meeting |
2022-08-17 | Interim 2022 Earnings Release |
2022-05-19 08:00 am | Q1 2022 Earnings Call |
2022-05-17 10:20 am | Q1 2022 Earnings Release |
2022-05-02 08:00 am | FY 2021 Earnings Call |
2022-04-27 | FY 2021 Earnings Release |
2021-12-14 04:00 am | Annual General Meeting |
2021-11-21 | Analyst Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 31,3 31,3 0.05% | 30,3 30,3 0.04% | 28,8 28,9 -0.22% | 25,7 27,0 -4.67% |
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -32,1 -31,2 -2.73% | 1,87 3,90 -52.08% |
EBIT Million EUR | Released Forecast Spread | -23,4 -23,8 1.64% | -7,61 -9,43 19.32% | -35,3 -35,4 0.17% | 1,12 3,10 -63.74% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,78 -5,25 9.01% | -12,7 -12,8 0.8% | 35,7 -37,8 194.52% | -43,2 -42,1 -2.64% |
Net income Million EUR | Released Forecast Spread | -7,36 -5,25 -40.15% | -13,0 -13,1 0.33% | 38,3 -32,1 219.37% | -44,2 -42,1 -4.91% |
EPS EUR | Released Forecast Spread | -3,36 -2,52 -33.33% | -5,04 -5,78 12.73% | 14,3 -9,66 247.83% | -16,2 -12,4 -30.51% |
Announcement Date | 20/04/20 | 12/04/21 | 30/04/22 | 28/04/23 |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 |
---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 6,57 9,70 -32.31% | 8,51 10,4 -18.17% |
EBIT Million EUR | Released Forecast Spread | 1,15 | |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -28,1 -5,10 -450.98% | -7,96 -5,40 -47.43% |
Net income Million EUR | Released Forecast Spread | -28,1 -5,10 -450.98% | -8,65 -5,40 -60.09% |
Announcement Date | 17/05/22 | 19/08/22 |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Biofrontera AG
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |